Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) FCF Margin (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported FCF Margin over the past 16 years, most recently at 8.92% for Q2 2025.

  • Quarterly results put FCF Margin at 8.92% for Q2 2025, down 693.0% from a year ago — trailing twelve months through May 2025 was 10.57% (up 357.0% YoY), and the annual figure for FY2025 was 10.57%, up 357.0%.
  • FCF Margin for Q2 2025 was 8.92% at Lifecore Biomedical, Inc. \De\, up from 12.11% in the prior quarter.
  • Over the last five years, FCF Margin for LFCR hit a ceiling of 55.97% in Q2 2022 and a floor of 102.32% in Q1 2022.
  • Median FCF Margin over the past 5 years was 15.82% (2024), compared with a mean of 19.2%.
  • Biggest five-year swings in FCF Margin: crashed -11963bps in 2023 and later surged 7950bps in 2024.
  • Lifecore Biomedical, Inc. \De\'s FCF Margin stood at 15.32% in 2021, then surged by 49bps to 7.74% in 2022, then tumbled by -41bps to 10.9% in 2023, then tumbled by -142bps to 26.35% in 2024, then soared by 134bps to 8.92% in 2025.
  • The last three reported values for FCF Margin were 8.92% (Q2 2025), 12.11% (Q1 2025), and 26.35% (Q4 2024) per Business Quant data.